What is MaxCyte's accounts receivable?

MaxCyte (MXCT) reported accounts receivable of $4.25M in Q1 2026.

How has MaxCyte's accounts receivable changed year-over-year?

MaxCyte's accounts receivable decreased by 23.1% year-over-year, from $5.53M to $4.25M.

What is the long-term trend for MaxCyte's accounts receivable?

Over 4 years (2021 to 2025), MaxCyte's accounts receivable has grown at a 6.9% compound annual growth rate (CAGR), from $17.68M to $23.09M.

What does accounts receivable mean?

Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.

MaxCyte MXCT Accounts Receivable

Accounts Receivable at other companies

Ginkgo BioworksDNA

$19.82M-24.6%

Rapid Micro BiosystemsRPID

$6.37M+40.8%

RepligenRGEN

$151.55M+2.8%

TEC

Bio-TechneTECH

$214.56M-9.5%

Prime MedicinePRME

$0-100%

Envista Holdings CorporationNVST

$436.6M+11.1%

Other financials

Income statement

See full

Revenue$9.7M-7.1%

Gross profit$8.1M-9.1%

Operating income-$6.2M+49.7%

Net income-$4.8M+53.7%

EPS (diluted)-$0.04+60.0%

Balance sheet

See full

Cash & equivalents$14.6M-37.8%

Total debt$17.5M-7.1%

Total equity$167.9M-15.8%

Total assets$194.5M-15.4%

Cash flow

See full

Operating cash flow-$8.2M+43.3%

CapEx$72.0K-89.0%

Free cash flow-$8.2M+45.3%

Valuation

See full

Market cap$130.15M-46.8%

Enterprise value$133.08M-46.3%

P/S4×-2.8×

Profitability

See full

Gross margin80.5%-0.4pp

Operating margin-141.8%+6.4pp

Net margin-121.2%+12.3pp

FCF margin-90.9%+3.7pp

Returns & leverage

See full

Return on equity-21.3%+2.0pp

Debt / equity0.1×0.0×

Current ratio12×-0.2×

Where this comes from

Reported directly by MaxCyte in its filing.

Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MaxCyte's accounts receivable?: MaxCyte (MXCT) reported accounts receivable of $4.25M in Q1 2026.
How has MaxCyte's accounts receivable changed year-over-year?: MaxCyte's accounts receivable decreased by 23.1% year-over-year, from $5.53M to $4.25M.
What is the long-term trend for MaxCyte's accounts receivable?: Over 4 years (2021 to 2025), MaxCyte's accounts receivable has grown at a 6.9% compound annual growth rate (CAGR), from $17.68M to $23.09M.
What does accounts receivable mean?: Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.